Volume 4 Supplement 1
P29 - Intestinal helminth Enterobius vermicularis as an immunomodulator factor
© Patsantara et al; licensee BioMed Central Ltd. 2014
Published: 28 February 2014
A growing body of evidence shows an inverse association between helminthic infestation and expression of allergy. It has been suggested that Enterobius vermicularis, the least pathogenic human intestinal nematode and the last one in westernized societies may have a modulatory effect on the human immune system.
Healthy Greek schoolchildren were investigated for E. vermicularis eggs with the adhesive-tape test. Sixty four of those, who were found parasitized and 67 matched controls were further assessed, using hematological and serological immune parameters, such as Eosinophil number (Eo count), serum Eosinophilic Cationic Protein (ECP), total and specific Immunoglobulin E (ΙgΕ) and the ratio of ECP/Eo count. In addition, certain cytokines were measured in parasitized children. These parameters were compared between not-parasitized and parasitized children, taking into account their atopic status, as well as history of clinically expressed allergic diseases.
Eo count, ECP and IgE levels were found higher in parasitized than in not-parasitized children (p≤.035 for all) indicating a type 2 immune response activation during infestation. Eo count and IgE were found significantly higher in the atopic group, whereas Eo count and ECP in the nonatopic one. However, the ECP/Eo count ratio did not significantly differ between the groups compared.As expected, atopic parasitized children exhibited higher serum IgE levels (p=.001) compared to nonatopic ones, although their IL-4 levels were paradoxically lower (p=.030). ECP was found lower (p=.016) in atopic children with a history of allergic disease than in those without such history, possibly indicating immunosuppression in the former group.
The results provide evidence that E. vermicularis elicits a protective Th2 oriented response, irrespective of the children’s atopic status. The parasite seems to contribute to an environment which might downregulate immune responses in atopic subjects, more so in those with a history of allergic disease.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.